Anwar Mohammad

InstitutionDasman Diabetes Institute
AddressKuwait
vCardDownload vCard
    Publication Timeline
    COVID-19 publications
    Bar chart showing 11 Covid-19 publications, with a maximum of 2 publications in April 2021 and July 2021
    All Publications
    Bar chart showing 16 publications over 7 distinct years, with a maximum of 8 publications in 2021
    These graphs show COVID-19 publications by month since August 2019 and all publications written by authors of COVID-19 publications over the past 30 years.

    To see the data from both graphs as text, click here.
    Publication Field Summary
    This graph shows the number and percent of publications by field. Fields are based on how the National Library of Medicine (NLM) classifies the publications' journals and might not represent the specific topics of the publications. Note that an individual publication can be assigned to more than one field. As a result, the publication counts in this graph might add up to more than the number of publications the person has written. To see the data as text, click here.
    Publication List
    Publications listed below are automatically derived from MEDLINE/PubMed and other sources, which might result in incorrect or missing publications.
    Sort By:     Newest   |   Oldest   |   Most Cited   |   Most Discussed
    PMC Citations indicate the number of times the publication was cited by articles in PubMed Central, and the Altmetric score represents citations in news articles and social media. (Note that publications are often cited in additional ways that are not shown here.) Fields are based on how the National Library of Medicine (NLM) classifies the publication's journal and might not represent the specific topic of the publication. Translation tags are based on the publication type and the MeSH terms NLM assigns to the publication. Some publications (especially newer ones and publications not in PubMed) might not yet be assigned Field or Translation tags.) Click a Field or Translation tag to filter the publications.
    1. Mohammad A, Abubaker J, Al-Mulla F. Structural modelling of SARS-CoV-2 alpha variant (B.1.1.7) suggests enhanced furin binding and infectivity. Virus Res. 2021 10 02; 303:198522. PMID: 34314772.
      Citations: 1     Fields:    Translation:Cells
    2. Khan A, Wei DQ, Kousar K, Abubaker J, Ahmad S, Ali J, Al-Mulla F, Ali SS, Nizam-Uddin N, Mohammad Sayaf A, Mohammad A. Preliminary Structural Data Revealed That the SARS-CoV-2 B.1.617 Variant's RBD Binds to ACE2 Receptor Stronger Than the Wild Type to Enhance the Infectivity. Chembiochem. 2021 08 17; 22(16):2641-2649. PMID: 34160124.
      Citations: 7     Fields:    Translation:HumansCells
    3. Mohammad A, Al-Mulla F, Wei DQ, Abubaker J. Remdesivir MD Simulations Suggest a More Favourable Binding to SARS-CoV-2 RNA Dependent RNA Polymerase Mutant P323L Than Wild-Type. Biomolecules. 2021 06 22; 11(7). PMID: 34206274.
      Citations:    Fields:    Translation:HumansCells
    4. Haddad D, John SE, Mohammad A, Hammad MM, Hebbar P, Channanath A, Nizam R, Al-Qabandi S, Al Madhoun A, Alshukry A, Ali H, Thanaraj TA, Al-Mulla F. SARS-CoV-2: Possible recombination and emergence of potentially more virulent strains. PLoS One. 2021; 16(5):e0251368. PMID: 34033650.
      Citations: 5     Fields:    Translation:HumansCells
    5. Khan A, Khan S, Saleem S, Nizam-Uddin N, Mohammad A, Khan T, Ahmad S, Arshad M, Ali SS, Suleman M, Wei DQ. Immunogenomics guided design of immunomodulatory multi-epitope subunit vaccine against the SARS-CoV-2 new variants, and its validation through in silico cloning and immune simulation. Comput Biol Med. 2021 06; 133:104420. PMID: 33930764.
      Citations: 8     Fields:    Translation:Humans
    6. Mohammad A, Alshawaf E, Marafie SK, Abu-Farha M, Al-Mulla F, Abubaker J. Molecular Simulation-Based Investigation of Highly Potent Natural Products to Abrogate Formation of the nsp10-nsp16 Complex of SARS-CoV-2. Biomolecules. 2021 04 14; 11(4). PMID: 33919870.
      Citations: 1     Fields:    Translation:HumansCells
    7. Khan A, Zia T, Suleman M, Khan T, Ali SS, Abbasi AA, Mohammad A, Wei DQ. Higher infectivity of the SARS-CoV-2 new variants is associated with K417N/T, E484K, and N501Y mutants: An insight from structural data. J Cell Physiol. 2021 10; 236(10):7045-7057. PMID: 33755190.
      Citations: 47     Fields:    Translation:HumansCells
    8. Al-Mulla F, Mohammad A, Al Madhoun A, Haddad D, Ali H, Eaaswarkhanth M, John SE, Nizam R, Channanath A, Abu-Farha M, Ahmad R, Abubaker J, Thanaraj TA. ACE2 and FURIN variants are potential predictors of SARS-CoV-2 outcome: A time to implement precision medicine against COVID-19. Heliyon. 2021 Feb; 7(2):e06133. PMID: 33532652.
      Citations: 6     
    9. Abu-Farha M, Al-Sabah S, Hammad MM, Hebbar P, Channanath AM, John SE, Taher I, Almaeen A, Ghazy A, Mohammad A, Abubaker J, Arefanian H, Al-Mulla F, Thanaraj TA. Prognostic Genetic Markers for Thrombosis in COVID-19 Patients: A Focused Analysis on D-Dimer, Homocysteine and Thromboembolism. Front Pharmacol. 2020; 11:587451. PMID: 33362545.
      Citations: 6     
    10. Mohammad A, Alshawaf E, Marafie SK, Abu-Farha M, Abubaker J, Al-Mulla F. Higher binding affinity of furin for SARS-CoV-2 spike (S) protein D614G mutant could be associated with higher SARS-CoV-2 infectivity. Int J Infect Dis. 2021 Feb; 103:611-616. PMID: 33075532.
      Citations: 11     Fields:    Translation:HumansCells
    11. Mohammad A, Marafie SK, Alshawaf E, Abu-Farha M, Abubaker J, Al-Mulla F. Structural analysis of ACE2 variant N720D demonstrates a higher binding affinity to TMPRSS2. Life Sci. 2020 Oct 15; 259:118219. PMID: 32768580.
      Citations: 5     Fields:    Translation:HumansCellsPHPublic Health
    Mohammad's Networks
    Click the
    Explore
    buttons for more information and interactive visualizations!
    Concepts (88)
    Explore
    _
    Co-Authors (41)
    Explore
    _
    Similar People (60)
    Explore
    _